Related Experiment Videos
Pathogenesis of the acute coronary syndromes and therapeutic implications
L Badimon1, J J Badimon, G Vilahur
1Cardiovascular Research Center, ICCC-CSIC, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. lbmucv@cid.csic.es
Insights
Atherosclerosis involves arterial plaque buildup and thrombosis, increasing cardiovascular risk. Treatments focus on plaque stabilization and reducing blood clots through lifestyle changes and medications like statins.
Area of Science:
- Cardiovascular Science
- Thrombosis Research
- Pharmacology
Background:
- Atherosclerosis leads to arterial lumen thickening and obstruction.
- Thrombosis from disrupted plaques accelerates clinical syndrome presentation.
- Plaque stabilization and thrombus reduction are key therapeutic goals.
Purpose of the Study:
- To review strategies for plaque stabilization.
- To discuss methods for reducing thrombus burden.
- To highlight pharmacological interventions for atherosclerosis.
Main Methods:
- Review of lifestyle modification benefits.
- Analysis of pharmacological strategies.
- Examination of agents targeting coagulation and platelet aggregation.
Main Results:
- Diet and lifestyle modifications reduce coronary risk.
- Statins, ACE inhibitors, fibrinolytics, anticoagulants, and antiplatelets are effective.
- These agents mitigate atherosclerosis impact and inhibit thrombogenesis.
Conclusions:
- Comprehensive strategies are essential for managing atherosclerosis.
- Pharmacological interventions play a crucial role in reducing cardiovascular events.
- Targeting plaque stability and thrombosis is vital for patient outcomes.
Abstract:
Atherosclerosis is characterized by the thickening and obstruction of the arterial lumen and thrombosis associated with vulnerable disrupted plaques seems to be responsible for the accelerated process of clinical syndrome presentation. Strategies to promote plaque stabilization and reduce thrombus burden have been one of the major targets of recent times. Modification of diet and lifestyle has important benefit in reducing coronary risk. Several pharmacological strategies for reducing cardiovascular morbidity and mortality have demonstrated effectiveness. Statins and angiotensin converting enzyme, fibrinolytics, inhibitors of the intrinsic coagulation cascade and anti-platelet agents have been developed to reduce the impact of atherosclerosis and inhibit thrombogenesis.